T cell recognition of melanoma-derived antigens: Implication for peptide based immunotherapy

被引：0
|
作者：
Rivoltini, L
Mazzocchi, A
Squarcina, P
Arienti, F
Belli, F
Castelli, C
Marincola, FM
Loftus, DJ
Parmiani, G
机构：
[1] NCI,NIH,BETHESDA,MD 20892
[2] NATL TUMOR INST,MILAN,ITALY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1313 / 1313
页数：1
相关论文
共 50 条
  • [41] CYTOTOXIC T-CELL RECOGNITION OF A HUMAN-MELANOMA DERIVED PEPTIDE WITH A CARBOXYL-TERMINAL ALANINE-PROLINE SEQUENCE
    MORIOKA, N
    KIKUMOTO, Y
    HOON, DSB
    MORTON, DL
    IRIE, RF
    MOLECULAR IMMUNOLOGY, 1995, 32 (08) : 573 - 581
  • [42] T cell recognition of breast cancer antigens
    Petersen, Nadia Viborg
    Andersen, Sofie Ramskov
    Andersen, Rikke Sick
    Straten, Per Thor
    Met, Ozcan
    Hadrup, Sine Reker
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 313 - 314
  • [43] Suppression of the maturation and activation of the dendritic cell line DC2.4 by melanoma-derived factors
    Hargadon, Kristian M.
    Forrest, Osric A.
    Reddy, Pranay R.
    CELLULAR IMMUNOLOGY, 2012, 272 (02) : 275 - 282
  • [44] T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
    Sim, Malcolm J. W.
    Sun, Peter D.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Human Malignant Melanoma-Derived Progestagen-Associated Endometrial Protein Immunosuppresses T Lymphocytes In Vitro
    Ren, Suping
    Chai, Lina
    Wang, Chunyan
    Li, Changlan
    Ren, Qiquan
    Yang, Lihua
    Wang, Fumei
    Qiao, Zhixin
    Li, Weijing
    He, Min
    Riker, Adam I.
    Han, Ying
    Yu, Qun
    PLOS ONE, 2015, 10 (03):
  • [46] Antigens recognized by melanoma-reactive T cells and the development of cancer immunotherapy
    Robbins, PF
    PATHOLOGIE BIOLOGIE, 1998, 46 (02): : 138 - 139
  • [47] DELAYED-TYPE CUTANEOUS HYPERSENSITIVITY (DTH) TO MELANOMA ANTIGENS - ITS IMPLICATION IN SPECIFIC IMMUNOTHERAPY IN CANCER
    MUKHERJI, B
    UCCI, A
    NATHANSON, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 355 - 355
  • [48] DELAYED-TYPE CUTANEOUS HYPERSENSITIVITY TO MELANOMA ANTIGENS AND ITS IMPLICATION IN ACTIVE SPECIFIC IMMUNOTHERAPY IN CANCER
    MUKHERJI, B
    ROTHMAN, L
    UCCI, A
    CASEY, HR
    LIN, CW
    MILLER, HH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1980, 8 (2-3) : 149 - 155
  • [49] Growth requirement for methionine in human melanoma-derived cell lines with different levels of MMACHC expression and methylation
    Bauer, William G.
    Watkins, David
    Zacharias, Caitlin
    Gilfix, Brian M.
    Rosenblatt, David S.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (01)
  • [50] MINOR HISTOCOMPATIBILITY ANTIGENS AS TARGETS FOR T-CELL IMMUNOTHERAPY
    Pilunov, A. M.
    Romaniuk, D. S.
    Efimov, G. A.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (03): : 322 - 345
12345